Web Exclusives

Treatment with ribociclib and an aromatase inhibitor or fulvestrant for hormone receptor–positive, HER2-negative metastatic breast cancer did not increase the risk of thrombosis in the real-world setting. Read More ›

Palbociclib combined with letrozole is associated with improved outcomes for patients with hormone receptor–positive, HER2-negative metastatic breast cancer with lung or liver metastases in the first-line setting Read More ›

Recently released results using liquid biopsy shows KRAS G12C mutation in patients with NSCLC can be lost or acquired at progressive disease. Read More ›

Social listening can offer investigators valuable information about unmet patient needs and concerns regarding their cancer treatment and to direct future research. Read More ›

Researchers found a large underrepresentation gap among minority populations across major cancer types in clinical trials. Read More ›

Improved understanding of self-care behaviors in patients with cancer who take oral anticancer medications can help healthcare professionals support patient medication adherence. Read More ›

During active chemotherapy treatment, adopting an aerobic exercise program may reduce cancer-related fatigue. Read More ›

Patient outcomes could be improved through targeted education for oncology nurses focused on managing treatment-related adverse events. Read More ›

A new landmark study, MONALEESA-3, demonstrates extended overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer. Read More ›

Page 1 of 44

Subscribe to The Oncology Nurse-APN/PA

To sign up for our newsletter or print publications, enter your contact information below.

I'd like to receive: